TPG and KKR in Race to Buy 20% Stake in Piramal’s Pharma Business Valued Over US$2bn
It was reported by several news media outlets that the US PE giants, TPG Capital or KKR may acquire a 20% stake in India’s Piramal Enterprises...
586 Views
Eris Lifesciences IPO - Rich Valuations at What Appears to Be Unsustainably High Margins
Eris Lifesciences plans to raise US$270m in its IPO through a selldown of shares by a ChrysCapital, a PE investor, and the founders. Our fellow...
575 Views